Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination Hemotherapy and Mortality Prevention (CHAMP) Study Rationale and Design.

Fiore1, Brophy, Peduzzi

  • 1Veteran's Affairs Medical Center, Boston, Massachusetts, US.

Journal of Thrombosis and Thrombolysis
|February 7, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The steam volatile oil of Wollemia nobilis and its comparison with other members of the Araucariaceae (Agathis and Araucaria).

Biochemical systematics and ecology·2000
Same author

Initiating and Maintaining Patients on Warfarin Anticoagulation: The Importance of Monitoring.

Journal of cardiovascular pharmacology and therapeutics·2000
Same author

The BeppoSAX View of the Hot Cluster Abell 2319.

The Astrophysical journal·1999
Same author

Purification and characterization of agarases from a marine bacterium, Vibrio sp. PO-303.

Journal of marine biotechnology·1999
Same author

beta-triketones from myrtaceae: isoleptospermone from leptospermum scoparium and papuanone from corymbia dallachiana

Journal of natural products·1999
Same author

Reply

The Journal of pediatrics·1999
Same journal

Multi target effects of Allium macrostemon against myocardial infarction: an integrated network pharmacology, molecular docking, and experimental study.

Journal of thrombosis and thrombolysis·2026
Same journal

Comparative effectiveness of figure-of-eight suture and manual compression for femoral venous hemostasis after atrial fibrillation ablation: A grade assessed meta-analysis.

Journal of thrombosis and thrombolysis·2026
Same journal

Tissue factor-related biomarkers during combined androgen blockade in patients with prostate cancer: A brief report.

Journal of thrombosis and thrombolysis·2026
Same journal

Opioid use disorder and clinical outcomes following percutaneous coronary intervention for acute coronary syndromes.

Journal of thrombosis and thrombolysis·2026
Same journal

Sex-based differences in clinical outcomes among cardiogenic shock patients treated with mechanical circulatory support.

Journal of thrombosis and thrombolysis·2026
Same journal

IGF-1 axis: The signalling bond in cancer-associated thrombosis and cachexia?

Journal of thrombosis and thrombolysis·2026
See all related articles

This study investigates if combining moderate-intensity oral anticoagulation with antiplatelet therapy improves survival after acute myocardial infarction compared to aspirin alone.

Area of Science:

  • Cardiology
  • Thrombosis Research
  • Pharmacology

Background:

  • Acute myocardial infarction (AMI) often results from disrupted atherosclerotic plaque and subsequent intracoronary thrombosis.
  • Early research suggested anticoagulation could prevent myocardial infarction, but clinical trial results remain inconclusive regarding optimal strategies.
  • Previous trials combining anticoagulants and antiplatelet agents showed mixed results, potentially due to low-intensity warfarin use.

Purpose of the Study:

  • To evaluate if combination therapy (moderate-intensity oral anticoagulation plus antiplatelet therapy) reduces overall mortality in AMI survivors.
  • To compare the efficacy of this combination therapy against aspirin monotherapy in preventing death post-myocardial infarction.

Main Methods:

  • The study proposes a clinical trial to assess the effectiveness of a specific combination hemotherapy regimen.

Related Experiment Videos

  • Participants will include survivors of acute myocardial infarction.
  • The primary endpoint will be the reduction in overall mortality.

    • Main Results:

    • This section is not applicable as the abstract describes a proposed trial and not its results.
    • Further research is needed to determine the efficacy of combination hemotherapy in AMI survivors.

    Conclusions:

    • A definitive conclusion cannot be drawn as the abstract outlines a proposed study.
    • The trial aims to resolve the ongoing debate on the benefits of combination antithrombotic therapy in acute myocardial infarction survivors.